Renaissance Technologies (RenTech)'s VYGR Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 578,024 shares of Voyager Therapeutics, Inc. (VYGR) worth $2.23 M, representing 0.00% of the portfolio. First purchased in 2017-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VYGR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 356,901 shares. Largest reduction occurred in Q1 2021, reducing 404,858 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Voyager Therapeutics (VYGR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Voyager Therapeutics (VYGR) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +281,574 | Add 94.98% | 578,024 | $3.86 |
| Q4 2025 | +34,000 | Add 12.95% | 296,450 | $3.93 |
| Q3 2025 | -129,650 | Reduce 33.07% | 262,450 | $4.67 |
| Q2 2025 | +271,900 | Add 226.21% | 392,100 | $3.11 |
| Q1 2025 | -19,700 | Reduce 14.08% | 120,200 | $3.38 |
| Q4 2024 | -138,767 | Reduce 49.80% | 139,900 | $5.67 |
| Q3 2024 | +215,467 | Add 340.93% | 278,667 | $5.85 |
| Q2 2024 | -64,900 | Reduce 50.66% | 63,200 | $7.91 |
| Q1 2024 | -55,000 | Reduce 30.04% | 128,100 | $9.31 |
| Q4 2023 | -220,500 | Reduce 54.63% | 183,100 | $8.44 |
| Q3 2023 | +90,600 | Add 28.95% | 403,600 | $7.75 |
| Q2 2023 | +180,700 | Add 136.58% | 313,000 | $0.01 |
| Q1 2023 | +13,000 | Add 10.90% | 132,300 | $0.01 |
| Q4 2022 | +2,500 | Add 2.14% | 119,300 | $0.01 |
| Q3 2022 | +22,500 | Add 23.86% | 116,800 | $5.92 |
| Q2 2022 | +94,300 | New Buy | 94,300 | $5.91 |
| Q1 2022 | -52,617 | Sold Out | 0 | $0.00 |
| Q4 2021 | -262,510 | Reduce 83.30% | 52,617 | $2.72 |
| Q3 2021 | -75,263 | Reduce 19.28% | 315,127 | $2.63 |
| Q2 2021 | -35,011 | Reduce 8.23% | 390,390 | $4.13 |
| Q1 2021 | -404,858 | Reduce 48.76% | 425,401 | $4.71 |
| Q4 2020 | +4,058 | Add 0.49% | 830,259 | $7.15 |
| Q3 2020 | -19,479 | Reduce 2.30% | 826,201 | $10.67 |
| Q2 2020 | -197,121 | Reduce 18.90% | 845,680 | $12.62 |
| Q1 2020 | -202,700 | Reduce 16.27% | 1.04 M | $9.15 |
| Q4 2019 | +172,600 | Add 16.09% | 1.25 M | $13.95 |
| Q3 2019 | +343,100 | Add 47.01% | 1.07 M | $17.21 |
| Q2 2019 | +237,500 | Add 48.24% | 729,801 | $27.22 |
| Q1 2019 | +60,000 | Add 13.88% | 492,301 | $19.14 |
| Q4 2018 | +356,901 | Add 473.34% | 432,301 | $9.40 |
| Q3 2018 | -20,200 | Reduce 21.13% | 75,400 | $18.93 |
| Q2 2018 | -115,965 | Reduce 54.81% | 95,600 | $19.54 |
| Q1 2018 | +211,565 | New Buy | 211,565 | $18.79 |
| Q4 2017 | -33,300 | Sold Out | 0 | $0.00 |
| Q3 2017 | +22,800 | Add 217.14% | 33,300 | $20.60 |
| Q2 2017 | +10,500 | New Buy | 10,500 | $8.95 |
Renaissance Technologies (RenTech)'s Voyager Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Voyager Therapeutics, Inc. (VYGR) in Q2 2017, acquiring 10,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Voyager Therapeutics, Inc. (VYGR) for 36 quarters since Q2 2017.
Renaissance Technologies (RenTech)'s largest addition to Voyager Therapeutics, Inc. (VYGR) was in Q4 2018, adding 432,301 shares worth $4.06 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 578,024 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $2.23 M.
As of the Q1 2026 filing, Voyager Therapeutics, Inc. (VYGR) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Voyager Therapeutics, Inc. (VYGR) was 1,245,501 shares, as reported at the end of Q4 2019.